LEO Pharma Inc. announced today that the Food and Drug Administration (FDA) has approved ANZUPGO® (delgocitinib) cream for the topical treatment of moderate-to-severe chronic hand eczema (CHE) in ...

The FDA granted fast track status to DB-1310, a HER3-targeting antibody-drug conjugate, for advanced nonsquamous non-small cell lung cancer.

News News: The Rajasthan Board (BSER) has announced the Class 10 and 12 supplementary exam schedule for 2025. Exams will begin on August 6 and run in morning shi ...

It is defined as mild, moderate, severe and very severe and can have a significant impact on a person’s day to day life.